Zoonotic Influenza, commonly known as avian flu, is a viral disease caused by several subtypes of the Influenza Type A virus, which are capable of infecting birds and being transmitted to humans. These viruses are classified according to their surface proteins, hemagglutinin (H) and neuraminidase (N), with H5N1 and H7N9 being the most relevant subtypes due to their potential to cause serious diseases and pandemics. Transmission to humans usually occurs through direct contact with infected birds or their excretions, although it is rare for the virus to spread from person to person.

In humans, symptoms can range from mild, such as fever and cough, to severe, including respiratory complications and pneumonia. Effective treatment includes antivirals administered early in the course of the disease. Understanding this disease is crucial for public health, especially due to the risk of the pandemic and its impact on food security and the economy in regions where poultry farming is significant.

Avian influenza viruses are mainly divided into two types: A and B.

Those of Type A are the most significant from a zoonotic point of view, as they include several subtypes that can infect both birds and humans. These subtypes are classified by their surface proteins, hemagglutinin (H) and neuraminidase (N). The best known and most dangerous to public health are H5 and H7, which have been responsible for serious outbreaks in poultry and sporadic cases of transmission to humans, some of which have resulted in severe illness or even death.

Type B of the Avian Influenza virus is less prevalent and typically causes milder illnesses that are not associated with pandemics. However, both types can mutate and evolve over time, underscoring the importance of continued surveillance to detect new, potentially dangerous variants. Accurate identification of these subtypes is crucial to direct appropriate prevention and control measures to protect both animal and human health.

Transmission of the Avian Influenza virus between animals generally occurs through direct contact with infected birds or through exposure to environments contaminated with the virus, such as water or surfaces where infected excretions (saliva, mucus and feces) are found. This mode of transmission is of particular concern in poultry farms and live bird markets, where population density and management practices can facilitate rapid spread of the virus among birds.

As for humans, the risk of infection increases significantly during the handling of infected birds without adequate protection, as well as during participation in their slaughter and processing. Although human-to-human transmission has been extremely rare, documented events have raised global concern, underscoring the importance of strict preventive measures and the use of personal protective equipment in high-risk situations. 

Factors that influence the transmission of the Avian Influenza virus include environmental aspects, such as the geographical location of farms and the migratory routes of wild birds. Migratory birds can act as carriers of the virus, introducing it into areas where domestic birds may be susceptible to infection, facilitating local outbreaks. Additionally, the seasons affect the survival and virulence of the virus, with wet and cold conditions often promoting greater persistence of the virus in the environment.

Additionally, agricultural and biosecurity practices play a crucial role in the spread of the virus. Farms with high bird densities, insufficient separation between domestic and wild birds, and poor cleaning and disinfection practices can significantly increase the risk of outbreaks. Implementing strict controls and improving hygiene conditions are essential steps to mitigate transmission and protect both animal and human health. 

In humans, the symptoms of Avian Influenza can vary widely, from mild forms that resemble the common flu, with fever, cough and sore throat, to severe forms that include acute respiratory complications such as pneumonia, difficulty breathing, and in severe cases, organ failure and death. These more severe manifestations typically occur with highly pathogenic subtypes such as H5N1, which have caused global concern due to their high mortality rate in confirmed cases.

The diagnosis of Avian Influenza in birds is generally made by virological tests that include isolation of the virus in cell cultures and identification by RT-PCR, which provides rapid and accurate confirmation of the viral subtype. These tests are carried out on swab samples from the trachea or cloaca collected from suspected birds. Early detection is essential to implement containment measures and prevent the spread of the virus to other farms and potentially to humans.

Prevention of Avian Influenza begins with biosecurity on farms, including access control to poultry facilities to prevent the entry of viruses through contaminated people, vehicles or equipment. It is recommended to maintain a clean and disinfected environment, with the regular application of procedures to disinfect equipment and facilities. Additionally, it is vital to avoid contact between domestic and wild birds, as migratory birds can carry variants of the Avian Influenza virus that can infect poultry.

Another important preventive measure is active surveillance, which includes regular monitoring of poultry populations for signs of the disease and testing for the virus. This surveillance helps identify early outbreaks and implement rapid responses that may include quarantine and culling of infected birds to limit spread. Education of poultry workers and the general public about the signs of the disease and prevention measures is also crucial for effective disease control.

When an outbreak of Avian Influenza is detected, it is essential to act quickly to contain the disease. This usually involves the implementation of restriction zones around the focus of the outbreak, where the movement of birds and poultry products is strictly controlled. Control strategies may also include depopulation, that is, stamping out affected and potentially exposed birds within a defined zone to eliminate the virus reservoir.

In addition to immediate response measures, vaccination can be used as a control tool, especially in regions where the disease is endemic. Vaccines against certain subtypes of the Avian Influenza virus can help reduce the incidence of the disease and reduce the viral load in the environment, although their use must be part of an integrated approach that includes good management practices and strict biosafety measures. . International collaboration and information sharing are also essential to control the spread of the virus globally. 

For birds, once Avian Influenza has been confirmed, there is no specific treatment to eradicate the virus. The main strategy focuses on prevention and control to prevent spread, which may include stamping out affected birds. In humans, treatment includes the use of antivirals such as oseltamivir or zanamivir, which have been shown to be effective in reducing the severity of symptoms and improving outcomes in patients infected with Avian Influenza subtypes when administered early in the course of the disease. disease.

These antivirals act by inhibiting the virus's neuraminidase, an enzyme that facilitates its spread within the host's body. Treatment is most effective when started within 48 hours of symptoms appearing, so early detection and rapid initiation of treatment are crucial. Additionally, in severe outbreak situations, health authorities may recommend additional preventive measures, such as antiviral prophylaxis for people at high risk of exposure. 

Prompt medical intervention not only benefits the infected person, helping to prevent serious complications and death, but also reduces the possibility of transmitting the virus to others. This is especially important in settings where prolonged, close contact can facilitate the spread of the virus. The prompt medical response includes isolation of suspected cases to prevent spread of the virus in the community and contact tracing to quickly identify and treat other possible cases.

In the context of an outbreak, rapid response also involves the implementation of public health measures such as bird market closures, travel restrictions and, in extreme cases, quarantines. These actions, combined with effective communication to the population about how to avoid the risk of infection, are essential to effectively manage the spread of the virus and protect public health. 

Research into vaccines against Avian Influenza has progressed significantly in recent years, with the development of several vaccines that aim to prevent infection in birds and sometimes in humans. These vaccines are designed to induce immunity against specific subtypes of the virus, such as H5N1 and H7N9, which are known for their zoonotic potential. In birds, vaccination has proven to be an effective tool to reduce the incidence of the disease and reduce the viral load in the environment, which in turn reduces the risk of transmission to humans.

In addition to traditional vaccines, recombinant vaccine and viral vector technologies are being explored that offer promise of more effective and long-lasting immunization. These new technologies allow a faster response to the emergence of new viral subtypes, since they can be quickly adapted to include specific genetic sequences of emerging viruses. International collaboration and the exchange of scientific information are crucial for the continued development of these vaccines and their effective implementation in public and animal health programs. 

The future of Avian Influenza research includes not only the development of new vaccines, but also the improvement of genomic surveillance strategies to more quickly detect and respond to new strains of the virus. This advanced surveillance will allow scientists and public health authorities to anticipate and mitigate outbreaks before they become global epidemics. Additionally, work is underway to improve antiviral treatments that may be effective against various subtypes of the virus, which is essential given the virus's ability to mutate and evade immune responses.

Another important focus is research on the transmission dynamics of the virus between different species, including zoonotic routes. Understanding how and why certain subtypes of the virus are able to cross species barriers and cause infections in humans will help develop more specific and targeted preventive measures. Additionally, improving understanding of the environmental and management factors that contribute to the spread of the virus will help design more effective interventions at the farm level and at the wildlife interface. 

Avian Influenza represents a serious threat to the poultry industry, as outbreaks can lead to enormous economic losses due to bird mortality, emergency depopulation, and restrictions on trade in birds and poultry products. Epidemics of highly pathogenic viruses, such as H5N1, have caused the death and culling of millions of birds in various outbreaks worldwide, resulting in significant financial losses for producers. Additionally, outbreaks can affect the price of poultry feed, increase biosecurity costs and reduce consumer confidence, negatively impacting the local and even global economy.

In addition to the direct effects, Avian Influenza outbreaks can lead to increased insurance costs and the need for significant investments in research and development of preventive measures, such as vaccines and improvements in biosafety practices. These factors together make disease control not only an animal and public health issue, but also a critical economic concern that requires careful management and effective mitigation strategies to protect the viability of the poultry industry. 

To minimize economic losses associated with Avian Influenza, it is essential to implement proactive prevention and control strategies. These include constant surveillance of poultry populations to detect the disease early, rigorous application of biosecurity measures on poultry farms, and continued education of producers and workers on best practices for managing and preventing outbreaks. Furthermore, vaccination of birds in regions where the disease is endemic can significantly reduce the prevalence of the virus and limit its economic impact.

International collaboration also plays a vital role in reducing economic losses by enabling the sharing of resources, information and technologies between countries and organizations. This includes establishing common protocols for trade in poultry and poultry products that can help prevent the spread of the virus across national borders. Finally, the development of compensation funds for farmers affected by outbreaks can provide necessary financial support and help maintain economic stability in the poultry sector. 

For those interested in learning more about Avian Influenza and how to prevent or manage it, numerous resources are available. Organizations like the World Health Organization (WHO), Center for Disease Control and Prevention (CDC) and World Organization for Animal Health (OIE) They offer a wealth of information on their websites, including prevention guides, updated surveillance data, and outbreak response protocols. These resources are essential for health professionals, veterinarians, poultry producers and the general public interested in public and animal health measures.

Additionally, many universities and research institutions provide studies and publications on Avian Influenza, which can be valuable resources for those seeking a deeper understanding of the virology, epidemiology, and control strategies of this disease. For direct and easy access, many of these resources are available online and can be consulted through academic search engines such as Google Scholar or specific health science databases. 

In the event of a suspected Avian Influenza outbreak, it is crucial to contact local health and veterinary authorities immediately. Each country usually has a specific ministry or department that handles zoonotic disease outbreaks, details of which can be found on government websites. Below are the health ministries of the member countries of the SICA region:

MINISTRY OF HEALTH EL SALVADOR
View link

MINISTRY OF HEALTH BELIZE
View link

MINISTRY OF HEALTH GUATEMALA
View link

SECRETARY OF HEALTH HONDURAS
View link

MINISTRY OF HEALTH COSTA RICA
View link

MINISTRY OF HEALTH PANAMA
View link

MINISTRY OF HEALTH DOMINICAN REPUBLIC
View link

In addition, it is advisable to have contacts of international organizations such as the WHO and OIE at hand, as they can offer technical support and guidance in outbreak management.

To facilitate rapid and effective response, many countries have hotlines and early warning systems to report suspected cases of diseases in animals or humans. These systems allow authorities to initiate investigations and containment measures in a timely manner to prevent the spread of the virus. Collaboration between communities, health professionals and health authorities is essential to effectively manage any emergency related to Avian Influenza. 

Avian influenza H5N1: summary of the current situation

Current avian influenza status in wild birds

Prevention and treatment of avian influenza virus infections in humans with antivirals

Avian Influenza (OMSA)

Avian Influenza (OPS)

Information about avian influenza OMSA

Technical Report: Highly Pathogenic Avian Influenza A (H5N1) Virus CDC

Avian Influenza Terrestrial Code OMSA

What you should know about avian influenza CDC

Surveillance of highly pathogenic avian influenza in wild birds FAO

"One Health" legislation: preventing pandemics through the FAO law

Avian Influenza and Wildlife OMSA

Avian influenza and wetlands RAMSAR

Avian Influenza Iowa State University

CDC

OMSA

FAO

OMS

Pennsylvania State University